+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Studying the predictive/prognostic role of thymidylate synthase genotypes in patients with colorectal cancer: Is one polymorphism enough?



Studying the predictive/prognostic role of thymidylate synthase genotypes in patients with colorectal cancer: Is one polymorphism enough?



Journal of Clinical Oncology 23(28): 7230-1; Author Reply 7231




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 050436121

Download citation: RISBibTeXText

PMID: 16192610

DOI: 10.1200/JCO.2005.02.0495


Related references

Thymidylate synthase expression levels: a prognostic and predictive role in advanced colorectal cancer. Oncology Reports 14(3): 657-662, 2005

Prognostic and predictive value of the thymidylate synthase expression in patients with non-metastatic colorectal cancer. European Journal of Surgical Oncology 31(8): 863-868, 2005

Thymidylate synthase polymorphism in sporadic colorectal and gastric cancer in Tunisian population: a predictive role in 5-fluorouracil based chemotherapy treatment. Medical Oncology 31(2): 825-825, 2014

Polymorphism of the thymidylate synthase gene and thymidylate synthase levels in colon cancer cell lines and different tissues of colorectal cancer patients. Nucleosides, Nucleotides & Nucleic Acids 23(8-9): 1381-1384, 2004

Topoisomerase-1 and thymidylate synthase primary tumor expression as prognostic and predictive factors for response to CPT-11 in advanced colorectal cancer patients. European Journal of Cancer 37(Supplement 6): S308, October, 2001

Prognostic and predictive value of thymidylate synthase expression in primary colorectal cancer. Anticancer Research 30(2): 645-651, 2010

Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil. Oncology 70(5): 366-377, 2006

Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy. Journal of Clinical Oncology 20(7): 1721-1728, 2002

Prognostic role of thymidylate synthase , thymidine phosphorylase/platelet derived endothelial cell growth factor and proliferation markers in patients with colorectal cancer. Proceedings of the American Association for Cancer Research Annual Meeting 40: 338, March, 1999

Thymidylate synthase expression in resectable and unresectable pancreatic cancer: role as predictive or prognostic marker?. International Journal of Colorectal Disease 22(1): 49-55, 2006

Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer. Journal of Clinical Oncology 20(7): 1735-1743, 2002

Thymidylate synthase and cyclin D1 protein expression in lymph node negative colorectal cancer: role as prognostic factors?. Hepato-Gastroenterology 59(118): 1859-1864, 2012

Thymidylate synthase gene polymorphism and survival of colorectal cancer patients receiving adjuvant 5-fluorouracil. Genetic Testing and Molecular Biomarkers 17(11): 799-806, 2014

Prognostic value of thymidylate synthase, topoisomerase-1 and Ki-67 in advanced colorectal cancer patients on irinotecan and fluorouracil treatment. Zhonghua Zhong Liu Za Zhi 27(5): 312-315, 2005

Thymidylate synthase expression pattern is a prognostic factor in patients of colorectal cancer treated with 5-fluorouracil. International Journal of Oncology 25(4): 877-885, 2004